【24h】

Digital antimicrobial susceptibility testing using the MilliDrop technology

机译:使用Millidrop Technology的数字抗微生物易感性测试

获取原文
获取原文并翻译 | 示例
           

摘要

We present the MilliDrop Analyzer (MDA), a droplet-based millifluidic system for digital antimicrobial susceptibility testing (D-AST), which enables us to determine minimum inhibitory concentrations (MICs) precisely and accurately. The MilliDrop technology was validated by using resazurin for fluorescence readout, for comparison with standard methodology, and for conducting reproducibility studies. In this first assessment, the susceptibility of a reference Gram-negative strain Escherichia coli ATCC 25922 to gentamicin, chloramphenicol, and nalidixic acid were tested by the MDA, VITEK (R) 2, and broth microdilution as a reference standard. We measured the susceptibility of clinically relevant Gram-positive strains of Staphylococcus aureus to vancomycin, including vancomycin-intermediate S. aureus (VISA), heterogeneous vancomycin-intermediate S. aureus (hVISA), and vancomycin-susceptible S. aureus (VSSA) strains. The MDA provided results which were much more accurate than those of VITEK (R) 2 and standard broth microdilution. The enhanced accuracy enabled us to reliably discriminate between VSSA and hVISA strains.
机译:我们提出了Milidrop分析仪(MDA),一种基于液滴的毫流系统,用于数字抗微生物易感性测试(D-AST),使我们能够精确准确地确定最小抑制浓度(MICS)。通过使用荧光读数的resazurin来验证Millidrop技术,用于与标准方法进行比较,并进行再现性研究。在第一种评估中,通过MDA,Vitek2和肉汤微量硫化作为参考标准,通过MDA,Vitek2,作为参考标准进行参考革兰氏阴性菌株大肠杆菌ATCC 25922至庆大霉素的敏感性。我们测量了临床相关克金黄色葡萄球菌对万古霉素的临床相关革兰氏阳性菌株的易感性,包括万古霉素中间体S. aureus(Visa),异质万古霉素中间体S. aureus(HVISA)和万古霉素 - 易感金黄色葡萄球菌(VSSA)菌株。 MDA提供了比Vitek(R)2和标准肉汤微量微量更准确的结果。增强的准确性使我们能够可靠地区分VSSA和HVISA菌株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号